Diseases, Conditions, Syndromes

Good news: Mild COVID-19 induces lasting antibody protection

Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping out antibodies against the virus that causes COVID-19, according to a study from researchers at Washington University ...

Diseases, Conditions, Syndromes

Factors ID'd for strong antibody response in COVID-19

(HealthDay)—Sex, age, and severity of disease can predict increased antibody response in COVID-19 survivors, according to a study published recently in the Journal of Clinical Investigation.

Medical research

Metabolite signature of COVID-19 reveals multi-organ effects

SARS-CoV-2, the virus responsible for COVID-19, can cause a wide range of symptoms, from none at all to severe respiratory stress, multi-organ failure and death. The virus notably targets the lungs, but many patients also ...

Neuroscience

New blood test for Alzheimer's developed

A new blood test for Alzheimer's disease has been developed under the leadership of researchers at the University of Gothenburg. The method is based on measuring a specific variant of tau protein in ordinary blood samples, ...

Oncology & Cancer

Prostate cancer 'fingerprint' detected in blood sample

Scientists at UCL have invented a new test to identify the earliest genetic changes of prostate cancer in blood: a process which could allow doctors to see if cancers have spread, monitor tumour behaviour and enable better ...

Alzheimer's disease & dementia

Protein misfolding as a risk marker for Alzheimer's disease

In symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicates a considerably higher risk of Alzheimer's disease—up to 14 years before a clinical diagnosis is made. Amyloid-β folding ...

page 1 from 4